Guardant Health (GH) co-CEO reports 70,000-share gift transfer between entities

Rhea-AI Filing Summary

Guardant Health, Inc. director and Co-Chief Executive Officer Helmy Eltoukhy reported two bona fide gift transactions involving common stock on 2026-08-11. A total of 35,000 shares of Guardant Health common stock were transferred from the Helmy A. Eltoukhy Revocable Trust, reducing that trust’s indirect holdings to 1,995,934 shares. On the same date, 35,000 shares were recorded as acquired as indirect holdings of The Eltoukhy Foundation. A footnote states that these entries reflect changes in form of ownership from the revocable trust to The Eltoukhy Foundation, indicating an internal re-titling of shares rather than an open-market purchase or sale.

Insider Trade Summary

70,000 shares gifted

Gift 2 txns

Insider Eltoukhy Helmy

Role Co-Chief Executive Officer

Type	Security	Shares	Price	Value
Gift	Common Stock F1	35,000	$0.00	$0.00
Gift	Common Stock F1	35,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,995,934 shares (Indirect, Shares held by Helmy A. Eltoukhy Revocable Trust); Common Stock — 35,000 shares (Indirect, Shares held by The Eltoukhy Foundation)

Footnotes (1)

1. F1. Reflects changes in form of ownership from Helmy A. Eltoukhy Revocable Trust to The Eltoukhy Foundation.

Key Figures

Shares gifted from revocable trust: 35,000 shares Shares acquired by The Eltoukhy Foundation: 35,000 shares Total shares involved in gifts: 70,000 shares +3 more

6 metrics

Shares gifted from revocable trust 35,000 shares Bona fide gift disposition by Helmy A. Eltoukhy Revocable Trust on 2026-08-11

Shares acquired by The Eltoukhy Foundation 35,000 shares Bona fide gift acquisition as indirect holdings on 2026-08-11

Total shares involved in gifts 70,000 shares Sum of two 35,000-share bona fide gift transactions

Revocable Trust holdings after transaction 1,995,934 shares Indirect common stock holdings following the gift disposition

Foundation holdings after transaction 35,000 shares Indirect common stock holdings of The Eltoukhy Foundation after gift

Price per share for gifts $0.0000 Reported transaction price for bona fide gift entries

Key Terms

Bona fide gift, indirect ownership, Revocable Trust, The Eltoukhy Foundation

4 terms

Bona fide gift financial

"transaction code "G" with description "Bona fide gift""

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

indirect ownership financial

"Both transactions are reported with indirect ownership through entities"

Revocable Trust financial

"Shares held by Helmy A. Eltoukhy Revocable Trust"

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

The Eltoukhy Foundation financial

"Shares held by The Eltoukhy Foundation"

FAQ

What insider stock transactions did GH’s Helmy Eltoukhy report on this Form 4?

Helmy Eltoukhy reported two bona fide gift transactions of Guardant Health common stock, each for 35,000 shares, reflecting a shift in ownership from a revocable trust to The Eltoukhy Foundation.

How many Guardant Health (GH) shares were moved in total in this gifting transaction?

In total, 70,000 shares of Guardant Health common stock were involved, recorded as two separate 35,000-share bona fide gifts on 2026-08-11 between entities associated with Helmy Eltoukhy.

What are Helmy Eltoukhy’s indirect Guardant Health (GH) holdings after these transactions?

After the transactions, indirect holdings include 1,995,934 shares held by the Helmy A. Eltoukhy Revocable Trust and 35,000 shares held by The Eltoukhy Foundation, as reported in the Form 4.

Were the reported GH insider transactions open-market buys or sells?

No. Both transactions are coded as G (bona fide gifts), with a footnote explaining they reflect changes in form of ownership between the revocable trust and The Eltoukhy Foundation, not market purchases or sales.

Does the Form 4 state that GH insider Helmy Eltoukhy used a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a plan. The transactions are reported as bona fide gifts reflecting a change in form of ownership, without reference to a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 06:22 PM Accepted by SEC EDGAR 08/12/2026 - 06:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eltoukhy Helmy

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		G		35,000(1)	D	$0	1,995,934	I	Shares held by Helmy A. Eltoukhy Revocable Trust
Common Stock	08/11/2026		G		35,000(1)	A	$0	35,000	I	Shares held by The Eltoukhy Foundation

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects changes in form of ownership from Helmy A. Eltoukhy Revocable Trust to The Eltoukhy Foundation.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)